Study identifier:I-613
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Omeprazole and Ranitidine in the Treatment of Patients with Erosive Esophagitis Not Responding to Treatment withH2-Receptor Antagonists: A Double-Blind, Controlled, Multicentre study.
Acid Reflux
N/A
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Nov 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|